Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Conditions
- Acute Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Adult Diffuse Large Cell Lymphoma
- Anaplastic Large Cell Lymphoma
- Burkitt Lymphoma
- Chronic Myeloid Leukemia, BCR-ABL1 Positive
- Chronic Myelomonocytic Leukemia
- Hodgkin Lymphoma
- Lymphoblastic Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle Cell Lymphoma
- Mixed Phenotype Acute Leukemia
- Myelodysplastic Syndrome
- Prolymphocytic Leukemia
- Refractory Chronic Lymphocytic Leukemia
- Refractory Follicular Lymphoma
- Refractory Marginal Zone Lymphoma
- Refractory Small Lymphocytic Lymphoma
Interventions
- PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
- DRUG: Cyclophosphamide
- DRUG: Cyclosporine
- BIOLOGICAL: Filgrastim
- DRUG: Fludarabine
- DRUG: Mycophenolate Mofetil
- DRUG: Mycophenolate Sodium
- RADIATION: Total-Body Irradiation
- DRUG: Treosulfan
- PROCEDURE: Bone Marrow Aspiration
- PROCEDURE: Bone Marrow Biopsy
- PROCEDURE: Echocardiography Test
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- PROCEDURE: Positron Emission Tomography
Sponsor
Fred Hutchinson Cancer Center
Collaborators